BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12097299)

  • 1. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.
    Watanabe R; Ohyama C; Aoki H; Takahashi T; Satoh M; Saito S; Hoshi S; Ishii A; Saito M; Arai Y
    Cancer Res; 2002 Jul; 62(13):3850-4. PubMed ID: 12097299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.
    Lokeshwar VB; Estrella V; Lopez L; Kramer M; Gomez P; Soloway MS; Lokeshwar BL
    Cancer Res; 2006 Dec; 66(23):11219-27. PubMed ID: 17145867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
    Lokeshwar VB; Cerwinka WH; Lokeshwar BL
    Cancer Res; 2005 Mar; 65(6):2243-50. PubMed ID: 15781637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
    Satoh M; Ito A; Nojiri H; Handa K; Numahata K; Ohyama C; Saito S; Hoshi S; Hakomori SI
    Int J Oncol; 2001 Oct; 19(4):723-31. PubMed ID: 11562747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of alpha-defensin is associated with bladder cancer invasiveness.
    Holterman DA; Diaz JI; Blackmore PF; Davis JW; Schellhammer PF; Corica A; Semmes OJ; Vlahou A
    Urol Oncol; 2006; 24(2):97-108. PubMed ID: 16520271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
    Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
    Zi X; Simoneau AR
    Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
    Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
    Chakraborty A; Guha S
    Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
    Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
    Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells.
    Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
    Br J Cancer; 1999 Apr; 79(11-12):1651-6. PubMed ID: 10206273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guérin in transitional cancer cell lines.
    Sandes E; Lodillinsky C; Cwirenbaum R; Argüelles C; Casabé A; Eiján AM
    Int J Mol Med; 2007 Dec; 20(6):823-8. PubMed ID: 17982689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells.
    Ito A; Asamoto M; Hokaiwado N; Takahashi S; Shirai T
    Cancer Lett; 2005 Feb; 219(1):105-12. PubMed ID: 15694670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.